As metal-free carbon based catalysts, boron (B)doped carbonaceous materials have proved to exhibit superior catalytic performance toward nitrogen reduction reaction. However, this strategy of heteroatom doping encounters the synthesis challenges of precise control of the doping level and homogeneous distribution of the dopants, and in particular, these materials cannot be utilized in electrochemical N 2 reduction because of poor electrical conductivity. Accordingly, via first-principles calculations, we here predicted two stable two-dimensional crystalline compounds: BC 6 N 2 and BC 4 N, which have small band gaps and uniform distribution of NRR active sp 2 -B species and holey structures. Between them, the BC 6 N 2 monolayer originally possesses nice NRR activity with limiting potentials of −0.47 V. In the proton-rich acid medium, the electronic properties of these two B−C−N monolayers could be further tailored to exhibit a metallic characteristic by H pre-adsorption. This drastically improves the conductivity and enhances their NRR performances as reflected by the limiting potentials of −0.15, −0.34, and −0.34 V for BC 6 N 2 via enzymatic, distal, and alternating mechanisms, respectively. Besides, NRR on BC 4 N through enzymatic mechanism proceeds as the limiting potential moderated from −1.20 to −0.90 V. More than that, the competing hydrogen evolution reaction can be effectively suppressed. The current investigation opens an avenue of designing a 2D crystalline phase of MFC catalysts independent of heteroatom doping and gives insightful views of surface functionalization as an impactful strategy to improve the electrocatalytic activity of metal-free catalysts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.